Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute Myeloid and Chronic Lymphocytic Leukemias

    NEXT STORY
    James E. Wagner Cultivation Corporation Expands Compassionate Care Program and Announces New Strains
    PREV STORY
    Marinus Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in Tuberous Sclerosis Complex
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Initial Clinical Results of Konica Minolta Healthcare’s Dynamic Digital Radiography Presented at ATS 2018 Annual Meeting

    WAYNE, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announced ...

    author_avatar
    NASDAQ Market News

    ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments

    author_avatar
    NASDAQ Market News

    Immatics Announces Third Quarter 2020 Financial Results and Business Update

    author_avatar
    NASDAQ Market News